Vision Fund

We focus on the most likely growth clusters in 2020s in digitalization, healthcare/demographics and sustainables/renewables.

Breakthrough Biotech

We invest in high quality biotech companies with regulatory tailwind from the FDA. The primary focus of the fund is companies with Breakthrough designation in cancer, immunooncology and genetherapy

Advice Capital Global

Advice Capital Global invests in attractive companies across sector, geography and size. Objective  The fund’s objective is to deliver an average yearly return of at least 8%. Furthermore, the fund seeks to deliver a yearly return corresponding to the global

Get our newsletter